HK1115125A1 - 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators - Google Patents
3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activatorsInfo
- Publication number
- HK1115125A1 HK1115125A1 HK08105161.4A HK08105161A HK1115125A1 HK 1115125 A1 HK1115125 A1 HK 1115125A1 HK 08105161 A HK08105161 A HK 08105161A HK 1115125 A1 HK1115125 A1 HK 1115125A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ethylidenehydrazino
- substituted heterocyclic
- heterocyclic compounds
- thrombopoietin receptor
- receptor activators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004355195 | 2004-12-08 | ||
| JP2005330891 | 2005-11-15 | ||
| PCT/JP2005/022907 WO2006062240A1 (fr) | 2004-12-08 | 2005-12-07 | Composes heterocycliques a substitution 3-ethylidenehydrazino utilises en tant qu’activateurs du recepteur de la thrombopoietine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1115125A1 true HK1115125A1 (en) | 2008-11-21 |
Family
ID=36021812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08105161.4A HK1115125A1 (en) | 2004-12-08 | 2008-05-08 | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8552031B2 (fr) |
| EP (1) | EP1819692A1 (fr) |
| JP (1) | JP4985402B2 (fr) |
| KR (1) | KR101215225B1 (fr) |
| AU (1) | AU2005312585B2 (fr) |
| CA (1) | CA2588979C (fr) |
| HK (1) | HK1115125A1 (fr) |
| IL (1) | IL183647A (fr) |
| MX (1) | MX2007006819A (fr) |
| NO (1) | NO20072753L (fr) |
| NZ (1) | NZ555466A (fr) |
| RU (1) | RU2395505C2 (fr) |
| TW (1) | TWI351954B (fr) |
| WO (1) | WO2006062240A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA82695C2 (uk) * | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
| RU2401259C2 (ru) * | 2004-12-14 | 2010-10-10 | Ниссан Кемикал Индастриз, ЛТД | Амидные соединения и активаторы рецептора тромбопоэтина |
| US7879318B2 (en) | 2006-01-23 | 2011-02-01 | Mcw Research Foundation, Inc. | Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand |
| JP5157900B2 (ja) * | 2006-06-07 | 2013-03-06 | 日産化学工業株式会社 | 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤 |
| EP2233561A4 (fr) | 2007-12-05 | 2013-01-16 | Nissan Chemical Ind Ltd | Procédé d'amplification d'une cellule souche hématopoïétique utilisant un composé hétérocyclique |
| WO2009072624A1 (fr) * | 2007-12-05 | 2009-06-11 | Nissan Chemical Industries, Ltd. | Procédé d'amplification d'une cellule souche hématopoïétique utilisant un composé hétérocyclique |
| US20100310535A1 (en) | 2007-12-05 | 2010-12-09 | Nissan Chemical Industries, Ltd. | Method for expanding hematopoietic stem cells using heterocyclic compound |
| WO2011049213A1 (fr) * | 2009-10-23 | 2011-04-28 | 日産化学工業株式会社 | Composés hétérocycles fusionnés et activateur du récepteur de la thrombopoïétine |
| JP6012605B2 (ja) | 2010-09-22 | 2016-10-25 | アリオス バイオファーマ インク． | 置換されたヌクレオチドアナログ |
| US8980865B2 (en) | 2011-12-22 | 2015-03-17 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| EP2827876A4 (fr) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | Combinaisons pharmaceutiques comprenant un analogue thionucléotidique |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6046696A (en) | 1995-06-07 | 1996-12-30 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| PT885242E (pt) | 1995-06-07 | 2008-06-18 | Glaxo Group Ltd | Péptidos e compostos que se ligam a um receptor de trombopoietina |
| US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| JPH1072492A (ja) | 1996-09-02 | 1998-03-17 | Hokuriku Seiyaku Co Ltd | ペプチド化合物 |
| JPH111477A (ja) | 1997-06-12 | 1999-01-06 | Hokuriku Seiyaku Co Ltd | １，４−ベンゾジアゼピン誘導体及びその用途 |
| AU9265698A (en) | 1997-09-02 | 1999-03-22 | Boehringer Mannheim Gmbh | Mpl-receptor ligands, process for their preparation, medicaments containing themand their use for the treatment and prevention of thrombocytopaenia and anaemia |
| JPH11152276A (ja) | 1997-11-20 | 1999-06-08 | Hokuriku Seiyaku Co Ltd | ベンゾジアゼピン誘導体 |
| GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
| WO2000066112A1 (fr) | 1999-05-03 | 2000-11-09 | Smithkline Beecham Corporation | Antagonistes du recepteur cxcr-4 et mimetiques de thrombopoietine |
| CA2380206A1 (fr) * | 1999-07-26 | 2001-02-01 | Shionogi & Co., Ltd. | Compositions medicamenteuses possedant une activite agoniste de la thrombopoietine |
| WO2001017349A1 (fr) | 1999-09-10 | 2001-03-15 | Smithkline Beckman Corporation | Mimétiques de thrombopoïétine |
| US6552008B1 (en) | 1999-09-24 | 2003-04-22 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| JP2001097948A (ja) | 1999-09-30 | 2001-04-10 | Torii Yakuhin Kk | トロンボポエチン受容体に親和性を有する化合物 |
| JP2003513965A (ja) | 1999-11-05 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | セミカルバゾン誘導体およびそれらのトロンボポエチン模倣物としての使用 |
| WO2001039773A1 (fr) | 1999-12-06 | 2001-06-07 | Smithkline Beecham Corporation | Mimetiques de thrombopoietine |
| TWI284639B (en) | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
| CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| WO2002049413A2 (fr) | 2000-12-19 | 2002-06-27 | Smithkline Beecham Corporation | Mimetiques de thrombopoietine |
| BR0206670A (pt) | 2001-01-26 | 2004-02-25 | Shionogi & Co | Compostos halogenados que exibem agonismo para receptor de trombopoietina |
| JP4145654B2 (ja) | 2001-01-26 | 2008-09-03 | 塩野義製薬株式会社 | トロンボポエチン受容体アゴニスト作用を有する環状化合物 |
| JPWO2002062775A1 (ja) | 2001-02-02 | 2004-06-10 | 山之内製薬株式会社 | ２−アシルアミノチアゾール誘導体又はその塩 |
| WO2002085343A1 (fr) * | 2001-03-01 | 2002-10-31 | Smithkline Beecham Corporation | Mimetiques de la thrombopoietine |
| DK1466912T3 (da) | 2002-01-18 | 2013-07-01 | Astellas Pharma Inc | 2-acylaminothiazolderivat eller salt deraf |
| JP2003238565A (ja) | 2002-02-19 | 2003-08-27 | Japan Tobacco Inc | 縮合環化合物及びそれら化合物を含んでなる血球増多薬 |
| US7851503B2 (en) * | 2002-08-14 | 2010-12-14 | Nissan Chemical Industries, Ltd. | Thrombopoetin receptor activator and process for producing the same |
| TWI324593B (en) * | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
| UA82695C2 (uk) * | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
| RU2401259C2 (ru) * | 2004-12-14 | 2010-10-10 | Ниссан Кемикал Индастриз, ЛТД | Амидные соединения и активаторы рецептора тромбопоэтина |
-
2005
- 2005-12-07 CA CA2588979A patent/CA2588979C/fr not_active Expired - Fee Related
- 2005-12-07 NZ NZ555466A patent/NZ555466A/xx not_active IP Right Cessation
- 2005-12-07 AU AU2005312585A patent/AU2005312585B2/en not_active Ceased
- 2005-12-07 KR KR1020077012913A patent/KR101215225B1/ko not_active IP Right Cessation
- 2005-12-07 WO PCT/JP2005/022907 patent/WO2006062240A1/fr active Application Filing
- 2005-12-07 JP JP2007526867A patent/JP4985402B2/ja not_active Expired - Fee Related
- 2005-12-07 MX MX2007006819A patent/MX2007006819A/es active IP Right Grant
- 2005-12-07 EP EP05816744A patent/EP1819692A1/fr not_active Withdrawn
- 2005-12-07 US US11/721,252 patent/US8552031B2/en not_active Expired - Fee Related
- 2005-12-07 TW TW094143203A patent/TWI351954B/zh not_active IP Right Cessation
- 2005-12-07 RU RU2007125639/04A patent/RU2395505C2/ru not_active IP Right Cessation
-
2007
- 2007-05-30 NO NO20072753A patent/NO20072753L/no not_active Application Discontinuation
- 2007-06-04 IL IL183647A patent/IL183647A/en not_active IP Right Cessation
-
2008
- 2008-05-08 HK HK08105161.4A patent/HK1115125A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1819692A1 (fr) | 2007-08-22 |
| IL183647A (en) | 2013-06-27 |
| NZ555466A (en) | 2010-08-27 |
| CA2588979A1 (fr) | 2006-06-15 |
| TW200626145A (en) | 2006-08-01 |
| KR20070104340A (ko) | 2007-10-25 |
| US8552031B2 (en) | 2013-10-08 |
| KR101215225B1 (ko) | 2012-12-26 |
| AU2005312585B2 (en) | 2012-01-12 |
| JP4985402B2 (ja) | 2012-07-25 |
| RU2007125639A (ru) | 2009-01-20 |
| AU2005312585A1 (en) | 2006-06-15 |
| NO20072753L (no) | 2007-07-17 |
| IL183647A0 (en) | 2007-09-20 |
| JP2008522956A (ja) | 2008-07-03 |
| US20090281317A1 (en) | 2009-11-12 |
| CA2588979C (fr) | 2013-01-22 |
| TWI351954B (en) | 2011-11-11 |
| MX2007006819A (es) | 2007-07-24 |
| RU2395505C2 (ru) | 2010-07-27 |
| WO2006062240A1 (fr) | 2006-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1115125A1 (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators | |
| HK1091809A1 (en) | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | |
| IL180587A0 (en) | Heterocyclic compounds | |
| HK1123038A1 (en) | Heterocyclic compounds | |
| EP1945028A4 (fr) | Composes de nicotinamide substitue | |
| PL1919907T3 (pl) | Związek heterocykliczny | |
| ZA200709051B (en) | Heterocyclic compound | |
| IL178086A0 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| EP1790650B1 (fr) | Nouveaux dérivés d'imidazoles substitués | |
| IL177059A0 (en) | Indazole-carboxamide compounds as 5-ht4 receptor agonists | |
| IL188550A0 (en) | Heterocyclic compounds as agonists for the thyroid receptor | |
| IL183665A0 (en) | Heterocyclic compounds as ccr2b antagonists | |
| ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
| AP2007004047A0 (en) | Substituted triazole derivatives as oxtocin antagonists | |
| TWI368617B (en) | Thiophene compounds and thrombopoietin receptor activators | |
| IL195158A0 (en) | Novel heterocyclic compounds | |
| EP1776112A4 (fr) | Composes heterocycliques comme agents pharmaceutiques | |
| EP1824825A4 (fr) | Pyridoxines substituees comme agents antiplaquettaires | |
| IL179888A0 (en) | Compounds as ccr5 antagonists | |
| EG26136A (en) | Heterocyclic aromatic compounds substituted as fungicides | |
| ZA200700162B (en) | Novel heterocyclic compounds | |
| EP1961754A4 (fr) | Compose heterocyclique bicyclique | |
| ZA200800142B (en) | Heterocyclic compound | |
| ZA200803017B (en) | Heterocyclic compounds | |
| ZA200704979B (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20161207 |